The global in vitro fertilization market size surpassed USD 29.53 billion in 2024 and is estimated to hit around USD 69.27 billion by 2034, expanding at a CAGR of 8.90% from 2024 to 2034. A study published by Statifacts a sister firm of Precedence Research.

Ottawa, April 08, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global in vitro fertilization market size is predicted to increase from USD 32.16 billion in 2025 to approximately USD 69.27 billion by 2034 expanding at a CAGR of 8.90% from 2024 to 2034. The in vitro fertilization market growth is driven by improved technologies in IVF treatments globally, increased research activities and funding, suitable government initiatives, advanced median age of women in childbearing years, and rising infertility rates.

Interested? Request a Sample Databook to Explore our Insights - https://www.statifacts.com/stats/databook-download/7278

Industry Snapshot

In vitro fertilization is a kind of assisted reproductive technology (ART) where eggs are fertilized with sperm outside of the human body, usually performed in a laboratory in a controlled setting. The word in vitro means outside the body. IVF involves a number of steps, including retrieving eggs from ovaries and artificially combining them with sperm in a lab for fertilization. The in vitro fertilization market growth is accelerated for single women or same-sex couples who wish to have a child; IVF can provide a great opportunity for helping them to become parents if intrauterine insemination has not been successful. IVF with donor sperm can help potential patients achieve this goal. You can undergo IVF treatment with or without a partner since donor eggs or sperm can be sourced from fertility centers and sperm banks.

The use of artificial intelligence in in vitro fertilization is one of the most promising advancements in the field. AI is being used to optimize the selection of embryos by analyzing high amounts of data, which includes images of embryos, to narrow down which embryos have to highest chances of resulting in a successful pregnancy. According to a report published in June 2023, currently, India conducts an average of 2-2.5 lakh IVF cycles per year and projections indicate that this figure may reach 5-6 lakh cycles annually.

In-Vitro Fertilization Market Key Highlights

• Europe led the market with the biggest market share of 39% in 2024.
• Asia Pacific is projected to expand at the fastest CAGR during the forecast period.
• By procedure type, the fresh donor segment has held the major revenue share in 2024.
• By procedure type, the frozen non-donor segment is predicted to grow at a remarkable CAGR over the projected period.
• By end user, the fertility clinics segment has held the largest market share in 2024.
• By end user, the surgical centers segment is predicted to experience the fastest growth rate in the market from 2025 to 2034.
• By Product, the equipment segment accounted for a considerable share of the in vitro fertilization market in 2024.
• By Product, the reagents & media segment is anticipated to growth with the highest CAGR in the market during the forecast period 2025 to 2034.
• By Type, the conventional IVF segment has held the major revenue share in 2024.
• By Type, the IVF with ICSI segment is predicted to expand at the fastest CAGR over the projected period.
• By instruments, the culture media segment captured the biggest market share in 2024.
• By Instrument, the disposable devices segment is expected to grow at a notable CAGR over the projected period.

Major Key Trends in In Vitro Fertilization Market:

Suitable government initiatives: The government in the Indian state of Karnataka has announced that IVF procedures are to be provided free of cost for patients who are holders of Below the Poverty Line (BPL) cards. Above Poverty Line (APL) cardholders will receive a 30% rebate on treatment costs. Private clinics are currently charging between IN₹ 150,000 - 300,000 (US$ 1748 - US$ 3496) for IVF-related procedures. This initiative ensures greater affordability.

Increasing median age of pregnancy: The quality of eggs declines with age, making pregnancies in older women difficult. Many IVF users select donor eggs from younger women or from their own cache of frozen embryos to ensure higher chances of a successful pregnancy.

Rising infertility rates: Changes in lifestyles, environmental toxins, the use of products with hormone disruptors, and other factors are all leading to declining fertility globally. For women with lower fertility looking to conceive, IVF is becoming essential. Part of the therapeutics used during in vitro fertilization stimulate ovaries to release more eggs, improving the chances of getting a healthier egg and successful fertilization.

Order the Premium Databook Today for the Discounted Rate of $1550! https://www.statifacts.com/order-databook/7278

Limitations & Challenges in In Vitro Fertilization Market:

Social and ethical concerns: Though IVF is a revolutionary procedure, it is marred by ethical issues, including equal access to IVF services, funding of IVF treatment, compromised informed consent, and the effect of religious beliefs on IVF policy-making.

High costs associated with fertility procedures: IVF treatment is expensive. IVF treatment is not cheap, and after paying for medication and blood tests, the costs can quickly mount up. The total cost of IVF in India can range from IN₹ 150,000 to IN₹ 500,000 or more, depending on many factors. This includes the basic IVF procedure, diagnostic tests, medications, and additional treatments.

Raise the risk of having more than one baby: Becoming pregnant with multiple babies carries a higher risk of pregnancy-related high blood pressure and diabetes, early labor and delivery, low birth weight, and birth defects than pregnancy with a single baby.

Development of In Vitro Fertilization Platforms: Market’s Largest Potential

The use of artificial intelligence (AI) in the IVF laboratory has the potential to enhance many aspects of IVF procedures, like sperm selection, fertilization assessment, oocyte quality, ploidy prediction, cell tracking, quality management, and micromanipulation. The growing adoption of automated IVF systems is expected to add more potential benefits, including a standardization of workflows, reduction in errors and contamination, and the potential for incremental system enhancement via machine learning. This is also expected to lower the overall cost of the procedure.

• In February 2025, an innovative fertility technology developed at Tel Aviv University is transforming the landscape of in vitro fertilization, offering renewed hope to couples struggling to conceive. The innovative method has shown a remarkable jump in success rates, increasing the likelihood of pregnancy from 34% to 65%, a breakthrough that may redefine fertility treatments worldwide.
  

The increasing demand for fertility treatment drives research and the development of technologies to improve IVF regimens and success. Advancements in fertility treatment technology are changing lives. New methods and tools, including sperm extraction, are making it easier for couples to conceive.

Regional Analysis:

Europe Held the Dominant Position: Technological Advancement to Support Growth

Europe held a significant share of the in vitro fertilization market in 2024. Rising demand for fertility treatment, growing awareness of assisted reproductive techniques, social acceptance of IVF, rise in fertility specialized centers and clinics, and government funding support are driving the growth of the market in Europe.

Europe is home to some of the most prominent IVF centers, with countries like Spain, the United Kingdom, and Denmark leading in the number of IVF procedures performed annually. The market is also fueled by a growing demand for fertility preservation, including egg freezing, as well as a shift in social norms, with more people opting for delayed parenthood. Regulatory frameworks vary across European countries, with some offering supportive policies, while others maintain stricter regulations, which impact the accessibility and affordability of IVF services.

What to Expect From Asian Countries Till 2034?

Asia Pacific is projected to host the fastest-growing market in the coming years. Favorable funding offered by the government in the Asia Pacific region, technological advancements, rising new cases of fertility, and rising availability of in vitro fertilization (IVF) technology treatment are driving the growth of the in vitro fertilization market in the region.

Top Asian Countries for In Vitro Fertilization Treatment

India: India is the leading country that has a high range of cheapest fertility treatment providers with all essential things that are required during IVF treatment in India. Experts suggest that India is the best choice for infertility treatment. The initial benefit is affordability or the best in maintaining an environment to enhance the percentage of success rate in every IVF clinic in India.

Japan: Japan is renowned for its innovative medical technology and highly specialized fertility treatments, making it a leading destination for IVF in Asia. The country is known for its rigorous standards of safety and excellence, with clinics offering procedures like embryo freezing, genetic screening, and ICSI (Intracytoplasmic Sperm Injection). The cost of an IVF cycle in Japan generally ranges between $10000 and $15000, reflecting the innovative techniques and high-quality care available.

In Vitro Fertilization Market Scope

Report Attribute	Key Statistics
Market Size in 2025	USD 32.16 Billion
Market Size by 2034	USD 69.27 Billion
Growth Rate from 2025 to 2034	CAGR of 8.90%
Base Year	2024
Forecast Period	2025 to 2034
Segments Covered	By Procedure Type, By End User, and By Product, By Type, By Instrument, and By Region
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Procedure Type Insights

The fresh donor segment held a dominant presence in the in vitro fertilization market in 2024. Fresh donor eggs and IVF can help couples facing female infertility, inheritable genetic conditions, diminished ovarian reserve due to age or other factors, and poor response to ovarian stimulation medication. The eggs are fertilized with sperm in the laboratory the resulting embryo is grown and monitored closely.

The frozen non-donor segment is expected to witness the fastest growth during the forecast period. This is mainly due to advancements in oocyte cryopreservation technology, which is resulting in a growing success rate for pregnancies performed through frozen eggs. Scaling these technological advancements is also leading to lower procedure and preservation costs. Not to mention, transferring frozen eggs is better for both patient health and micromanipulation by the healthcare provider.

End-user Insights

The fertility clinic segment accounted for a considerable share of the in vitro fertilization market in 2024. Fertility clinics play an important role in our healthcare system by helping couples identify fertility issues and find resourceful solutions. Before IVF treatments are undertaken, the patient has to undergo a number of tests to check their hormone levels and the state of their reproductive health through various physical exams. These may also include getting an ultrasound scan and other tests to see if there are any blockages or structural problems in the uterus, ovaries, and fallopian tubes. Men are also often asked to get a semen analysis done to test sperm quality.

• In September 2024, a dedicated center for in vitro fertilization (IVF) services was launched by MGM Healthcare. The newly established Varam IVF Center at MGM Healthcare aims to provide advanced fertility centers and personalized care, bringing together specialists with innovative technology and extensive ancillary services all under one roof.
  

The surgical centers segment is projected to experience the highest growth rate in the market between 2025 and 2034. The development of several surgical treatment options to mitigate infertility in women can be used to enhance fertility. Procedures such as a hysteroscopy, tubal ligation reversal, and laparoscopy are some of the available options.

Product Insights

The equipment segment led the in vitro fertilization market. There are various pieces of equipment used in IVF, including a state-of-the-art air quality system, XiltriX monitoring and alarm system, SQA automated semen analyzer, matcher, three inverted microscopes with attached Narishige micromanipulators and laser systems, and four laminar flow hoods.

The reagents & media segment is set to experience the fastest rate of market growth from 2025 to 2034. IVF culture media can provide the necessary nutrients, pH levels, and energy sources to support the growth of embryos. Clinically proven, low lactate, single-step culture medium that helps maintains efficient metabolic rates by reducing unnecessary stress.

Type Insights

The conventional IVF segment registered its dominance over the in vitro market in 2024. Conventional IVF is recommended for blocked or damaged fallopian tubes, normal or slightly altered sperm parameters, couples preferring a less invasive procedure, and women with low ovarian reserves seeking a more natural approach.

The IVF with ICSI segment is projected to expand rapidly in the market in the coming years. According to the Society for Assisted Reproductive Technology (SART), the average live birth rate per IVF cycle with ICSI is nearly 30-35% for women under 35.

• According to a report, the fertilization rate, clinical pregnancy rate, and live birth rate were all statistically comparable between the two groups, with c-IVF achieving 7.8% and ICSI 4.3% live birth rates.
  

Instrument Insights

The culture media segment captured a significant portion of the in vitro fertilization market in 2024. Embryo culture media is designed to provide a nurturing environment. An embryo culture system is the specific combination of environmental conditions, technical equipment, and particular nutrients that embryos require for optimal growth.

The disposable devices segment will gain a significant share of the market over the studied period of 2025 to 2034. They were devices used for sperm and oocyte collection, manipulation, culture, and storage.

Browse More Research Reports:

• The global next-generation in vitro diagnostics market size is calculated at USD 96 billion in 2024 and is predicted to reach around USD 163.98 billion by 2034, expanding at a CAGR of 5.5% from 2025 to 2034.
• The U.S. infectious disease in vitro diagnostics market size accounted for USD 7,510 million in 2024 and is predicted to touch around USD 9,800 million by 2034, growing at a CAGR of 2.7% from 2025 to 2034.
• The U.S. in vitro diagnostics market size accounted for USD 41,440 million in 2024 and is predicted to touch around USD 72,140 million by 2034, growing at a CAGR of 5.7% from 2025 to 2034.
• The U.S. in vitro diagnostics contract manufacturing market size was valued at USD 8.19 billion in 2024 and is expected to be worth around USD 21.44 billion by 2034, growing at a compound annual growth rate (CAGR) of 10.1% during the forecast period 2025 to 2034.
• The global in vitro diagnostics market size accounted for USD 102.08 billion in 2024 and is expected to exceed around USD 133.24 billion by 2034, growing at a CAGR of 2.7% from 2024 to 2034.
• The U.S. fertility market size is calculated at USD 5,750 million in 2024 and is predicted to reach around USD 9,190 million by 2034, expanding at a CAGR of 4.8% from 2025 to 2034.
• The global infertility treatment market size is predicted to gain around USD 3,884 million by 2034 from USD 1,902 million in 2024 with a CAGR of 7.4% from 2025 to 2034.
  

Order the Premium Databook Today for the Discounted Rate of $1550! https://www.statifacts.com/order-databook/7278

In Vitro Fertilization Market Top Companies:

• AmbroiseParé Group
• Amedes MVZ Cologne GmbH
• AMP Center St Roch
• AVA Clinic Scanfert
• Bangkok IVF center
• Betamedics
• Biofertility Center
• Bloom Fertility and Healthcare
• Bloom Fertility Center
• Bourn Hall Fertility Center

Recent Breakthroughs in the Global In Vitro Fertilization Market:

• In March 2025, the upcoming launch of its latest offering- TMRW Vault- a state-of-the-art liquid nitrogen smart tank and digital workstation was announced by TMRW Life Sciences (TMRW), the fertility technology company transforming the storage and management of frozen eggs, embryos, and sperms.
• In November 2024, an AI-powered platform to boost patient support in assisted reproductive technology (ART) was launched by SpOvum. The platform offers personalized information based on individual ART-related concerns, drawing from reliable, indexed medical guides to provide fact-based, tailored answers.  

Segments Covered in the Report

By Procedure Type

• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

By End User

• Fertility Clinics
• Surgical Centers
• Hospitals
• Research Institutes

By Product

• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other Equipments
• Reagents & Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
  • Accessories

By Type

• Conventional IVF
• IVF with ICSI
• IVF with Donar Eggs
• Others

By Instrument

• Culture Media
• Disposable Devices
• Capital Equipment
  

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
  

You can place an order or ask any questions, please feel free to contact us at sales@statifacts.com

Statifacts offers subscription services for data and analytics insights. This page provides options to explore and purchase a subscription tailored to your needs, granting access to valuable statistical resources and tools. Access here - https://www.statifacts.com/get-a-subscription

Contact US

• Ballindamm 22, 20095 Hamburg, Germany
• Web: https://www.statifacts.com/
• Europe: +44 7383 092 044
  

About US

Statifacts is a leading provider of comprehensive market research and analytics services, offering over 1,000,000 market and custoer data sets across various industries. Their platform enables businesses to make informed strategic decisions by providing full access to statistics, downloadable in formats such as XLS, PDF, and PNG.

Our Trusted Data Partners:

Precedence Research | Towards Healthcare | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Dental | Towards EV Solutions | Nova One Advisor 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.